Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04893603

To Evaluate Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis

A Prospective, Multi-center, Single-arm Clinical Trial to Evaluate the Safety and Effectiveness of Transcatheter Aortic Valve System in Patients With Severe Aortic Stenosis With or Without Moderate or Lower Degree Regurgitation

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Chengdu Silara Meditech Inc. · Industry
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

To Evaluate the Safety and Effectiveness of Transcatheter Aortic Valve System ( Chengdu Silara Medtech Inc. ,Chengdu, China)in Patients with Severe Aortic Stenosis with or without Moderate or Lower Degree Regurgitation

Detailed description

Transcatheter Aortic Valve System (Chengdu Silara Medtech Inc. ,Chengdu, China) will be used for this study.

Conditions

Interventions

TypeNameDescription
DEVICETranscatheter Aortic Valve SystemProcedure: Transcatheter aortic valve replacement

Timeline

Start date
2020-12-16
Primary completion
2022-12-31
Completion
2026-12-31
First posted
2021-05-19
Last updated
2021-05-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04893603. Inclusion in this directory is not an endorsement.